Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest Logos Global Management LP Stock Portfolio

$1.24Billion– No. of Holdings #50

Logos Global Management LP Performance:
2024 Q1: 9.49%YTD: 9.49%2023: 24.51%

Performance for 2024 Q1 is 9.49%, and YTD is 9.49%, and 2023 is 24.51%.

About Logos Global Management LP and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Logos Global Management LP reported an equity portfolio of $1.2 Billions as of 31 Mar, 2024.

The top stock holdings of Logos Global Management LP are IDYA, IMCR, IMVT. The fund has invested 5.3% of it's portfolio in IDEAYA BIOSCIENCES INC and 4.7% of portfolio in IMMUNOCORE HLDGS PLC.

The fund managers got completely rid off ARGENX SE (ARGX), RAYZEBIO INC and AMBRX BIOPHARMA INC (AMAM) stocks. They significantly reduced their stock positions in CYTOKINETICS INC (CYTK), TOURMALINE BIO INC and COMPASS PATHWAYS PLC (CMPS). Logos Global Management LP opened new stock positions in SAREPTA THERAPEUTICS INC (SRPT), GERON CORP (GERN) and CELLDEX THERAPEUTICS INC NEW (CLDX). The fund showed a lot of confidence in some stocks as they added substantially to ENLIVEN THERAPEUTICS INC, SILENCE THERAPEUTICS PLC (SLN) and ASTRIA THERAPEUTICS INC (ATXS).
Logos Global Management LP Equity Portfolio Value
Last Reported on: 15 May, 2024

Logos Global Management LP Annual Return Estimates Vs S&P 500

Our best estimate is that Logos Global Management LP made a return of 9.49% in the last quarter. In trailing 12 months, it's portfolio return was 52.17%.

New Buys

Ticker$ Bought
sarepta therapeutics inc51,784,000
geron corp29,700,000
celldex therapeutics inc new27,280,500
vera therapeutics inc24,794,000
adverum biotechnologies inc21,210,000
cybin inc16,540,000
xencor inc14,384,500
cg oncology inc13,170,000

New stocks bought by Logos Global Management LP

Additions

Ticker% Inc.
enliven therapeutics inc412
silence therapeutics plc269
astria therapeutics inc128
immunocore hldgs plc125
spyre therapeutics inc66.67
immunovant inc47.92
ocular therapeutix inc45.29
viridian therapeutics inc16.67

Additions to existing portfolio by Logos Global Management LP

Reductions

Ticker% Reduced
cytokinetics inc-93.85
tourmaline bio inc-65.11
compass pathways plc-48.4
atyr pharma inc-47.01
annexon inc-38.38
structure therapeutics inc-32.71
applied therapeutics inc-18.67
ideaya biosciences inc-16.67

Logos Global Management LP reduced stake in above stock

Sold off

Ticker$ Sold
ambrx biopharma inc-29,904,000
ventyx biosciences inc-4,940,000
acelyrin inc-9,325,000
edgewise therapeutics inc-10,393,000
avidity biosciences inc-7,013,750
repare therapeutics inc-4,380,000
rayzebio inc-35,323,300
revolution medicines inc-10,038,000

Logos Global Management LP got rid off the above stocks

Sector Distribution

Logos Global Management LP has about 76.3% of it's holdings in Healthcare sector.

Sector%
Healthcare76.3
Others23.7

Market Cap. Distribution

Logos Global Management LP has about 5.4% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
MID-CAP33
SMALL-CAP29.2
UNALLOCATED23.7
MICRO-CAP7.9
LARGE-CAP5.4

Stocks belong to which Index?

About 58.6% of the stocks held by Logos Global Management LP either belong to S&P 500 or RUSSELL 2000 index.

Index%
RUSSELL 200058.6
Others41.4
Top 5 Winners (%)%
NUVB
nuvation bio inc
468.6 %
JANX
janux therapeutics inc
265.2 %
AGLE
spyre therapeutics inc
193.8 %
DYN
dyne therapeutics inc
110.2 %
APLT
applied therapeutics inc
91.4 %
Top 5 Winners ($)$
DYN
dyne therapeutics inc
27.5 M
OCUL
ocular therapeutix inc
20.7 M
IDYA
ideaya biosciences inc
15.1 M
GERN
geron corp
11.4 M
ANNX
annexon inc
9.1 M
Top 5 Losers (%)%
ALLK
allakos inc
-53.9 %
IMVT
immunovant inc
-19.2 %
VRDN
viridian therapeutics inc
-18.0 %
IMUX
immunic inc
-12.0 %
ADVM
adverum biotechnologies inc
-12.0 %
Top 5 Losers ($)$
IMVT
immunovant inc
-13.6 M
CYTK
cytokinetics inc
-11.3 M
OLMA
olema pharmaceuticals inc
-4.8 M
ALLK
allakos inc
-4.3 M
RCKT
rocket pharmaceuticals inc
-3.9 M

Logos Global Management LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Logos Global Management LP

Logos Global Management LP has 50 stocks in it's portfolio. About 40.3% of the portfolio is in top 10 stocks. IMVT proved to be the most loss making stock for the portfolio. DYN was the most profitable stock for Logos Global Management LP last quarter.

Last Reported on: 15 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions